Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-19-000584

Options or other derivatives

  • Director acquired 126,700 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Braunstein Scott Director 2018-12-31 Grant or award · Stock Option (right to buy) +126,700 126,700 D
Loading xslF345X03/doc4.xml…